Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.

Nanas, J N; Kontoyannis, D A; Alexopoulos, G P; Anastasiou-Nana, M I; Tsagalou, E P; Stamatelopoulos, S F; Moulopoulos, S D

Nanas, J N; Kontoyannis, D A; Alexopoulos, G P; Anastasiou-Nana, M I; Tsagalou, E P; Stamatelopoulos, S F; Moulopoulos, S D.

Affiliation

Nanas JN; University of Athens School of Medicine, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece.

Chest ; 119(4): 1173-8, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11296186

Subject(s)

Adrenergic beta-Agonists/administration & dosage; Amiodarone/administration & dosage; Anti-Arrhythmia Agents/administration & dosage; Cardiotonic Agents/administration & dosage; Dobutamine/administration & dosage; Heart Failure/drug therapy; Administration, Oral; Creatinine/blood; Drug Therapy, Combination; Female; Heart Failure/physiopathology; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Sodium/blood; Stroke Volume; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cardiotonic Agents / Adrenergic beta-Agonists / Dobutamine / Heart Failure / Amiodarone / Anti-Arrhythmia Agents Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Chest Year: 2001 Document type: Article Affiliation country: Greece Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links